SAT Clarifies Royalty Deductibility for Related-Party Technology Licenses: 5 Key Takeaways for Foreign Investors
On October 15, 2024, the State Administration of Taxation (国家税务总局, SAT, guójiā shuìwù zǒngjú) issued Public Notice No. 42 of 2024, formally clarifying the deductibility conditions for royalty payments made under related-party technology licensing agreements. The new guidance, effective from January 1, 2025, introduces a three-pronged “benefit test” that foreign-invested enterprises must satisfy to claim royalty deductions. This is a significant tightening — over 70% of transfer pricing disputes in China between 2020 and 2024 involved royalty payments to related parties, and SAT audits of such arrangements increased by 35% in that same period.
Background: The SAT’s Crackdown on Base Erosion and Profit Shifting (BEPS)
China has been an active participant in the OECD’s Base Erosion and Profit Shifting (BEPS) framework since 2015. The SAT’s focus on related-party royalty payments stems from a long-standing concern: multinational enterprises (MNEs) have used excessive royalty payments to shift profits out of China, eroding the corporate income tax (CIT) base. Before this update, the deductibility of such payments was governed by the general arm’s length principle under the 特别纳税调整 (Special Tax Adjustment, STA, tèbié nàshuì tiáozhěng) rules in the Corporate Income Tax Law.
The 2024 notice codifies what many tax professionals had observed in practice: the SAT is increasingly rejecting royalty deductions where the licensee cannot demonstrate actual economic benefit from the licensed technology. Between 2020 and 2024, the average CIT adjustment amount per STA case involving royalties rose from RMB 12.8 million to RMB 21.3 million, reflecting both stricter enforcement and larger-scale audits.
Key Changes: The Three-Pronged “Benefit Test” for Royalty Deductibility
The core of Public Notice No. 42 is a mandatory three-part test that all related-party technology licensing agreements must pass for royalty payments to be deductible. The three conditions are cumulative:
- Economic Substance: The licensee must prove actual usage of the technology in its Chinese operations, including evidence of implementation, training records, and integration into production processes.
- Value Creation: The licensed technology must demonstrably contribute to the licensee’s revenue, cost savings, or operational efficiency. A simple “license and pay” structure without measurable outcomes will fail this test.
- No Duplication: The royalty must not compensate for services, intellectual property, or assets already paid for through other intercompany transactions (e.g., management fees or marketing services).
A failure to satisfy any single prong results in a full disallowance of the royalty deduction for that tax year. Additionally, the SAT has clarified that retroactive adjustments can be made for open tax years — meaning agreements signed as far back as 2020 are now subject to review under the new framework.
| Aspect | Previous Practice (Pre-2025) | Public Notice No. 42 (Effective 2025) |
|---|---|---|
| Deductibility test | General arm’s length principle | Three-pronged benefit test (substance + value + non-duplication) |
| Documentation burden | Contemporaneous TP documentation | Contemporaneous TP documentation + benefit evidence package |
| Retroactive risk | Low (only under special audit) | High — open years (2020+) subject to retroactive adjustment |
| Average adjustment per case (2024) | RMB 12.8 million (2020 baseline) | RMB 21.3 million (2024 average) |
| Withholding tax treatment | 10% on gross royalty (treaty rate may apply) | 10% on gross royalty, but denial of deduction effectively increases CIT burden on licensee |
For foreign licensors, the practical implication is clear: a Chinese subsidiary that cannot deduct a royalty payment faces a higher effective CIT rate. If a subsidiary pays RMB 10 million in royalties and the deduction is denied, its taxable profit increases by the same amount, resulting in an additional RMB 2.5 million in CIT (assuming 25% rate) — on top of the 10% withholding tax already remitted.
Documentation Requirements: What Foreign Licensors Must Prepare
Public Notice No. 42 explicitly lists the documents that must be maintained to support the benefit test. The SAT now expects a “benefit evidence package” submitted alongside the annual corporate income tax return. Required items include:
- A technical implementation report signed by the licensee’s chief engineer or equivalent, detailing how the licensed technology was deployed
- Financial reconciliation showing the royalty’s contribution to revenue or cost reduction (e.g., a comparison of pre- and post-license margins)
- An intercompany agreement analysis demonstrating no overlap with other related-party charges (e.g., service fees, marketing contributions)
- Independent third-party valuation (for agreements exceeding RMB 5 million annually)
These requirements mirror the SAT’s increased focus on economic substance — a trend that began with the 2022 STA guidelines but is now codified specifically for royalties. The penalty for non-compliance is severe: failure to provide the benefit evidence package by the filing deadline results in an automatic 50% disallowance of the deduction, with a possibility of full disallowance if the SAT deems the documentation “materially deficient.”
Foreign investors should note that the SAT has also signaled a willingness to conduct desk audits specifically on royalty deductions. In 2024, the SAT’s Beijing branch audited 38 FIEs with related-party royalty payments above RMB 10 million annually, and 29 of those audits (76%) resulted in adjustments. The new notice is likely to expand this practice nationwide.
Risk Implications for Foreign-Invested Enterprises (FIEs)
For existing licensing arrangements, the risk of retroactive adjustments is the most immediate concern. The SAT’s notice explicitly states that open tax years (those still within the statute of limitations, typically 5 to 10 years depending on the nature of the transaction) can be revisited under the new interpretation. This means an FIE that signed a royalty agreement in 2020 and has been deducting payments annually now faces potential adjustments for 2020 through 2024 tax years.
Consider a typical scenario: a U.S. parent licenses proprietary manufacturing software to its Chinese subsidiary, with an annual royalty of RMB 8 million (5% of net sales). Under the old rules, the subsidiary deducted the full amount. Under the new benefit test, the SAT may argue that the software is a standard ERP tool already amortized in the subsidiary’s books, and the royalty is, therefore, a disguised dividend. The result: disallowance of RMB 8 million per year for 5 years = RMB 40 million in additional taxable income, leading to RMB 10 million in additional CIT plus potential late-payment surcharges (0.05% per day, which for 5 years could exceed RMB 3 million).
Foreign investors should also consider the impact on China’s tax treaty network. Most treaties (including the U.S.-China treaty) reduce the withholding tax rate on royalties to 10%, but the new rules do not change this rate — they affect deductibility. A licensor receiving the same net royalty after withholding is not directly impacted, but the licensee’s higher tax burden may strain the transfer pricing model, potentially leading to disputes over profit allocation.
NEXT STEPS: 3 Actions for Foreign Executives
- Conduct a “benefit test” audit of all existing related-party license agreements before the January 1, 2025 effective date. Use the SAT’s three-pronged framework to identify vulnerable arrangements. For a step-by-step audit checklist, see our detailed guide: How to Audit Your China Royalty Agreements Under SAT Notice No. 42
- Restructure intercompany charging models where royalty payments fail the duplication prong. Consider converting to a bundled technology and service agreement with a single, substantiated fee. Read our comparison: Royalty vs. Service Fee: Which Transfer Pricing Model Survives SAT Scrutiny?
- Engage a qualified transfer pricing advisor to prepare the benefit evidence package before the 2025 filing deadline. We recommend starting 6 months in advance. Learn more: Transfer Pricing Documentation and Compliance Services for Foreign Investors
— China Gateway 360 —
Remote China market entry support, built around execution.
